Notes / Company

Solara Active Pharma Sciences Ltd.

SOLARA BSE 541540 ISIN INE624Z01016 CDMO

Fundamentals

Market cap: ₹2,745 cr
ROE: 0.05%
Debt / equity: 0.71
52-week range: 422.85 — 734.20

Research on Tijori Finance

Company snapshot

Solara Active Pharma Sciences Ltd.

CDMO

₹2,643 cr

Latest quarter · Mar 2026

Sales₹387 cr

Net profit₹10 cr

Op. margin+14.9%

EPS₹2.16

Strength & growth

Debt / equity0.71×

Current ratio0.77×

Sales CAGR−0.2%

The timeline — 1 note on Solara Active Pharma Sciences Ltd.

May 2026

21 May 26 · 12:46 PM IST Brief

Brief · Concalls · Small cap

Solara appoints bankers to explore options for loss-making ibuprofen unit

Base business hits eight-quarter high in revenue and EBITDA at 26% margins, but Vizag facility and ibuprofen drag persist. Debt-free target set for FY29.

Verify on exchange BSE filings for SOLARA NSE filings for SOLARA Tijori Finance company page